Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of Vortioxetine (Lu AA21004) in Treating Adults With Major Depressive Disorder

ClinicalTrials.gov ID: NCT00672958

Public ClinicalTrials.gov record NCT00672958. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 11:03 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study Comparing the Efficacy and Safety of Lu AA21004 Versus Placebo in Acute Treatment of Adults With Major Depressive Disorder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine the efficacy and safety of once daily vortioxetine (Lu AA21004) in adults with major depressive disorder.

Study identification

NCT ID
NCT00672958
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Takeda
Industry
Enrollment
600 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2008 (Type not available)
Primary completion
Nov 2008 (Actual)
Completion
Nov 2008 (Actual)
Last update posted
Dec 13, 2013

2008

United States locations

U.S. sites
30
U.S. states
19
U.S. cities
30
Facility City State ZIP Site status
Not listed Birmingham Alabama — —
Not listed Cerritos California — —
Not listed Encino California — —
Not listed Fresno California — —
Not listed San Diego California — —
Not listed Farmington Connecticut — —
Not listed Jacksonville Florida — —
Not listed North Miami Florida — —
Not listed Tampa Florida — —
Not listed Hoffman Estate Illinois — —
Not listed Lafayette Indiana — —
Not listed Valparaiso Indiana — —
Not listed Shreveport Louisiana — —
Not listed Saint Paul Minnesota — —
Not listed Florissant Missouri — —
Not listed Saint Charles Missouri — —
Not listed Las Vegas Nevada — —
Not listed Rochester New York — —
Not listed Dayton Ohio — —
Not listed Toledo Ohio — —
Not listed Tulsa Oklahoma — —
Not listed Philadelphia Pennsylvania — —
Not listed Lincoln Rhode Island — —
Not listed North Charleston South Carolina — —
Not listed Nashville Tennessee — —
Not listed Houston Texas — —
Not listed Lake Jackson Texas — —
Not listed Wichita Falls Texas — —
Not listed Brown Deer Wisconsin — —
Not listed Middleton Wisconsin — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00672958, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 13, 2013 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00672958 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →